Metraipolis › archive › dc_6dbf04151c39

Effects of re-challenge with temozolomide in grade 2/3 IDH mutant gliomas at first progression — Europe PMC PMID:40836201

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40836201
DOI
10.1007/s11060-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-10T12:14:22.180Z
SHA-256 of the archived text
c4df4d7f6d1a4c7c3016a7b679df442e4ee15423f18c4ef3b7e9f1dce4d5afef
Stable URL of this page
https://metraipolis.com/documento/dc_6dbf04151c39

How to cite

Effects of re-challenge with temozolomide in grade 2/3 IDH mutant gliomas at first progression — Europe PMC PMID:40836201 — Europe PMC (en), https://europepmc.org/article/MED/40836201 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6dbf04151c39 (Metraipolis archive dc_6dbf04151c39, sha256 c4df4d7f6d1a4c7c3016a7b679df442e4ee15423f18c4ef3b7e9f1dce4d5afef)
BibTeX
@misc{dc6dbf04151c39,
  title = {Effects of re-challenge with temozolomide in grade 2/3 IDH mutant gliomas at first progression — Europe PMC PMID:40836201},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40836201},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6dbf04151c39; sha256 c4df4d7f6d1a4c7c3016a7b679df442e4ee15423f18c4ef3b7e9f1dce4d5afef},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40836201. Agents can read the archived copy with the MCP tool read_document.